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Background
The hopes placed in the new treatment regimens for
tuberculosis (TB), with the emergence of rifampicin were
partially shaded by the side effects which were frequently
recorded, able to impose temporary or definitive aban-
donment of this tuberculostatic.
Case report
The patient to be presented illustrates relapse of TB infec-
tion, in the context of significant comorbidities: chronic
renal failure, uremic stage, in chronic hemodialysis pro-
gram; primary hyperuricemia with urate nephropathy; stage
II arterial hypertension with very high cardiovascular risk.
In the absence of clinical, definite biological and mor-
phological criteria, the diagnosis of drug hepatopathy relies
predominantly on causal relationship between the drug
administration and the occurrence of the therapeutic acci-
dent. Non-hepatitis jaundice (liver tests normal) occurred
after 2 weeks of daily tuberculosis treatment, suggesting
the involvement of rifampicin in the conjugation of biliru-
bin and conjugated bilirubin excretion in the bile. The
peculiarity of the case: In the patient presented, the funda-
mental mechanism behind the cholestatic syndrome con-
sisted of: compromising the active transport of bilirubin
through the liver cell, without being present the reflux of
bile constituents (e.g., bile acids) in the circulation.
Conclusion
Adverse reactions to drugs due to their frequency and
harmfulness have opened a new nosology chapter in mod-
ern medicine. Adverse effects of tuberculostatic drugs
affect in a negative way both the management and the
dynamics of TB infection.
Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompanying
images. A copy of the written consent is available for
review by the Editor of this journal.
Authors’ details
1Dr. Victor Babeş University of Medicine and Pharmacy, Timişoara, Romania.
2Dr. Victor Babeş Clinical Hospital of Infectious Diseases and Pneumology,
Timişoara, Romania. 3Clinical Emergency Children’s Hospital “Dr. L. Turcanu”,
Timişoara, Romania.
Published: 15 October 2014
doi:10.1186/1471-2334-14-S7-P48
Cite this article as: Laza et al.: Non hepatitis jaundice - adverse reaction
to rifampicin. BMC Infectious Diseases 2014 14(Suppl 7):P48.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
* Correspondence: ruxi_martincu@yahoo.com
1Dr. Victor Babeş University of Medicine and Pharmacy, Timişoara, Romania
Full list of author information is available at the end of the article
Laza et al. BMC Infectious Diseases 2014, 14(Suppl 7):P48
http://www.biomedcentral.com/1471-2334/14/S7/P48
© 2014 Laza et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
